Brugada syndrome drugs to preferably avoid

Brugada syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Differentiating Brugada syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Examples of Type I Brugada Syndrome
Chest X Ray
Echocardiography or Ultrasound
Electrophysiologic Studies
Genetic Testing
Treatment
Treatment
Drugs to Avoid
Drugs to Preferably Avoid
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Brugada syndrome drugs to preferably avoid On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Brugada syndrome drugs to preferably avoid All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Brugada syndrome drugs to preferably avoid
CDC on Brugada syndrome drugs to preferably avoid
Brugada syndrome drugs to preferably avoid in the news
Blogs on Brugada syndrome drugs to preferably avoid
Directions to Hospitals Treating Brugada syndrome
Risk calculators and risk factors for Brugada syndrome drugs to preferably avoid

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The following drugs should be avoided in patients with Brugada syndrome.